Propel Bio Management, LLC Q4 2025 Filing
Filed February 11, 2026
Portfolio Value
$117.1M
Holdings
20
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (20 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | PAGPPLAINS GP HLDGS L P | 1,272,360 | $24.4M | 20.79% | |
| 2 | SP4PACHIEVE LIFE SCIENCES INC | 3,786,425 | $18.8M | 16.07% | |
| 3 | PHATPHATHOM PHARMACEUTICALS INC | 740,918 | $12.3M | 10.49% | |
| 4 | VRDNVIRIDIAN THERAPEUTICS INC | 282,531 | $8.8M | 7.51% | |
| 5 | MISTMILESTONE PHARMACEUTICALS | 4,118,321 | $8.3M | 7.10% | |
| 6 | KYTXKYVERNA THERAPEUTICS INC | 666,666 | $6.3M | 5.35% | |
| 7 | CMPSCOMPASS PATHWAYS PLC | 861,778 | $5.9M | 5.08% | |
| 8 | IVAINVENTIVA SA - ADR | 1,000,000 | $4.7M | 3.97% | |
| 9 | DCTHDELCATH SYSTEMS INC | 438,509 | $4.4M | 3.78% | |
| 10 | ABEOABEONA THERAPEUTICS INC | 830,780 | $4.4M | 3.74% | |
| 11 | TCE2CELLDEX THERAPEUTICS INC | 154,300 | $4.2M | 3.58% | |
| 12 | NKTRNEKTAR THERAPEUTICS | 82,822 | $3.5M | 2.99% | |
| 13 | OCSOCULIS HOLDING AG | 172,839 | $3.5M | 2.95% | |
| 14 | SABSSAB BIOTHERAPEUTICS INC | 652,881 | $2.4M | 2.08% | |
| 15 | RGNXREGENXBIO INC | 116,896 | $1.7M | 1.44% | |
| 16 | LONAATHIRA PHARMA INC | 149,279 | $1.1M | 0.96% | |
| 17 | LENZLENZ THERAPEUTICS INC | 59,085 | $945K | 0.81% | |
| 18 | AARDAARDVARK THERAPEUTICS INC | 46,408 | $609K | 0.52% | |
| 19 | ZVRAZEVRA THERAPEUTICS INC | 63,683 | $570K | 0.49% | |
| 20 | KLRSKALARIS THERAPEUTICS INC | 42,053 | $354K | 0.30% |